Develops the EnzyPad diagnostic device for haemophilia patients.
| Date | Round | Amount |
|---|---|---|
| Nov 2022 | Series A Nijmegen-based Radboud spin-out Enzyre raised a USD12M Series A led by Oost NL, with i&i Biotech Fund, Demcon, Takeda Ventures and Novalis Biotech. | $12.2M |
| Jul 2020 | Debt Dutch diagnostics startup Enzyre secured a EUR1.4M Corona Bridge Loan from the Dutch government, with Novalis Biotechnology Incubation participating. | $1.6M |
Tap an investor to see what else they have backed.
Data is community-curated and may be incomplete.